Vergis, Marissa .
HRN: 29-06-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2026
CLINDAMYCIN 300MG (CAP)
05/29/2026
06/05/2026
PO
300mg
TID
PROM
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines